NeuroSense Therapeutics Ltd. Rightofuse Assets
NeuroSense Therapeutics Ltd. (NRSN) had Rightofuse Assets of $153.00 thousand as of 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:RightofuseAssets · last filed 2024-04-04
- 2023-12-31: Rightofuse Assets $153.00K.
- 2023-06-30: Rightofuse Assets $191.00K.
- 2022-12-31: Rightofuse Assets $229.00K.
- 2022-06-30: Rightofuse Assets $268.00K.
| Period end | Rightofuse Assets |
|---|---|
| 2023-12-31 | $153.00K 20-F · filed 2024-04-04 |
| 2023-06-30 | $191.00K 6-K · filed 2023-08-16 |
| 2022-12-31 | $229.00K 20-F · filed 2024-04-04 |
| 2022-06-30 | $268.00K 6-K/A · filed 2023-01-19 |
| 2021-12-31 | $5.00K 20-F · filed 2022-04-14 |
| 2020-12-31 | $3.00K 20-F · filed 2022-04-14 |